Laryngeal tuberculosis in renal transplant recipients: a case report and review of the literature by Cialente, Fabrizio et al.
 ISSN: 1512-8601 (Print) | ISSN: 1840-4812 (Online) | OPEN ACCESS 
Journal Impact Factor® (2018): 1.458 
CiteScore® (December 2019): 2.13 
www.bjbms.org | blog.bjbms.org 
 
The BJBMS publishes an “Advanced online” manuscript format as a free service to authors in order to expedite the 
dissemination of scientific findings to the research community as soon as possible after acceptance following peer review and 
corresponding modification (where appropriate). An “Advanced online” manuscript is published online prior to 
copyediting, formatting for publication and author proofing, but is nonetheless, fully citable through its Digital Object 
Identifier (doi®). Nevertheless, this “Advanced online” version is NOT the final version of the manuscript. When the 
final version of this paper is published within a definitive issue of the journal with copyediting, full pagination, etc. the new final 
version will be accessible through the same doi and this "Advanced online" version of the paper will disappear. 
 
CASE REPORTS MICROBIOLOGY 
 
Fabrizio Cialente, et al.: Running title 
Laryngeal tuberculosis in renal transplant 
recipients: A case report and review of the 
literature 
Fabrizio Cialente1, Michele Grasso1, Massimo Ralli1, Marco de Vincentiis2, Antonio Minni1, 
Griselda Agolli1, Michele Dello Spedale Venti3, Mara Riminucci3, Alessandro Corsi3, Antonio 
Greco1 
1Department of Sense Organs, Sapienza University of Rome, Rome, Italy 
2Department of Oral and Maxillofacial Sciences, Sapienza University of Rome, Rome, Italy 
3Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy 
*Corresponding author: Michele Grasso, Department of Sense Organs, Sapienza University of 
Rome, Viale del Policlinico, 155, Rome 00186, Italy. Phone: +39 06 4997 6804. 
E-mail: michele.grasso@uniroma1.it 
 
DOI: https://dx.doi.org/10.17305/bjbms.2020.4448 
Submitted: 09 September 2019/Accepted: 20 February 2020 
Conflict of interest statement: The authors declare no conflict of interests 
Licence: © The Author(s) (2020). This work is licensed under a Creative Commons Attribution 4.0 
International License  
ABSTRACT 
Renal allograft recipients are at greater risk of developing tuberculosis than the general population. 
A woman with a kidney transplant was admitted to the emergency department with high 
temperature, dysphonia, odynophagia, and asthenia. The final diagnosis was laryngeal tuberculosis. 
Multidisciplinary collaboration enabled accurate diagnosis and successful treatment. Laryngeal 
tuberculosis should be considered in renal allograft recipients with hoarseness. A more rapid 
diagnosis of tuberculosis in renal transplant recipients is desirable when the site involved, such as 
the larynx, exhibits specific manifestations and the patient exhibits specific symptoms. In these 
cases, prognosis is excellent, and with adequate treatment, a complete recovery is often achieved. 
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INTRODUCTION 
Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis [1]. 
Geographically, most TB cases in 2018 were in Southeast Asia (44%), Africa (24%), and the 
Western Pacific nations (18%); smaller numbers of cases have occurred in eastern Mediterranean 
nations (8%), the Americas (3%), and Europe (3%) [1]. In 2018, the number of new cases of 
rifampicin-resistant TB was approximately half a million, of which 78% were multidrug-resistant 
TB [1]. Although the prevalence of TB is low in Italy, its epidemiology is changing. Since 1955, 
more than 160,000 people in Italy have died from this potentially preventable and curable disease 
[10]. In 2018, the estimated incidence of TB in Italy was 4300 new cases (7 cases per 100,000 
population), and the estimated number of deaths from TB in Italy was 370. The number of TB case 
notifications in 2018 in Italy was 3912 (71% with pulmonary involvement) [1]. 
Although the lung is the most common site of involvement, a number of extrapulmonary organs, 
including the larynx, can be involved as well. Laryngeal TB is an uncommon condition and has 
been rarely reported in the literature [1,2]. Nevertheless, it represents a public health concern [3] 
and may appear similar to malignancy on imaging and laryngoscopy [4,5].  
Renal allograft recipients are at greater risk of developing tuberculosis (TB), commonly atypical 
and extrapulmonary, than is the general population. The prevalence of TB in renal transplant 
recipients ranges from 1% to 4% in developed Western countries [6-9]. 
We present the case of a kidney transplant recipient who developed laryngeal TB. This case 
represents a rare condition. 
CASE REPORT 
A 38-year-old woman with chronic renal failure caused by chronic diabetes mellitus from the age of 
9 was admitted to the emergency department of the Sapienza University Hospital, Rome, Italy, in 
December 2018 with high temperature, dysphonia, odynophagia, general discomfort, and severe 
asthenia. She reported having undergone a thoracotomy with right-sided pneumectomy at the age of 
16 for previous pulmonary aspergillosis and renal transplantation in 2015 at the age of 35 and 
subsequent treatment with steroids, mycophenolate mofetil, and tacrolimus. Laryngeal and 
pulmonary mycosis were initially suspected, and she was transferred to the Department of 
Infectious Diseases and treated with antimycotic drugs. 
A neck and pulmonary computed tomographic (CT) scan showed asymmetry of the glottic space 
with marked contrast enhancement of the epiglottis up to the false right vocal fold; submucosal 
imbibition up to the thyroid cartilage, which appeared to be inhomogeneous with pseudo-focality; 
and right-sided level II lymphadenopathy with a maximum lymph node diameter of 12 mm. We 
also found right-sided lung atelectasis with ipsilateral mediastinal displacement (as a result of the 
earlier thoracotomy with right pneumectomy) and hyperplasia of the left lung with interstitial 
thickening. Otolaryngologic examination with high-definition fiber optic laryngoscopy (Figure 1) 
showed swelling of the right false vocal fold with a whitish lesion; motility and respiratory space 
were normal. Endoscopy of the larynx with narrow-band imaging confirmed that the lesion was not 
malignant. 
The patient underwent microlaryngoscopy under general anesthesia, and a biopsy sample of the 
whitish lesion was obtained. Histologic examination (Figure 2) revealed that the mucosa was lined 
by respiratory epithelium free from atypia. Lymphocyte-rich inflammatory infiltrates, along with 
multiple small, nonnecrotizing granulomatous aggregates of epithelioid histiocytes (CD68R+), were 
detected in the lamina propria. Ziehl-Neelsen and periodic acid–Schiff staining did not yield 
conclusive findings. Subsequent microbiologic bronchoalveolar lavage and sputum tests confirmed 
the diagnosis of pulmonary TB with extrapulmonary laryngeal extension. The patient was then 
isolated for 30 days and treated daily with 200 mg of isoniazid, 400 mg of ethambutol, 500 mg of 
pyrazinamide, 400 mg of moxifloxacin, and 300 mg of vitamin B6 (Benadon). As of this writing, 
the patient is not isolated and undergoes regular follow-up visits with clinical examinations and CT 
scans every 2 months.  
DISCUSSION 
Renal transplant recipients at high risk for different infections because they must receive 
immunosuppressive therapy [11]. Using the keywords “laryngeal TB” and “kidney transplant,” we 
searched PubMed for articles written in English from 1990 and on about the occurrence of laryngeal 
TB in kidney transplant recipients. Inclusion criteria were kidney transplantation and laryngeal TB, 
and we included only articles in which laryngeal involvement occurred before or at the same time as 
pulmonary involvement. We reviewed five reports about a total of eight patients [9-10,12-13]. In 
these cases, laryngeal symptoms were prominent (dysphonia, hoarseness) and directed the 
diagnosis. We excluded one article in which the authors diagnosed laryngeal TB after the 
occurrence of pulmonary TB (in a patient with cavitary pulmonary TB who was found to have 
laryngeal TB 1 year after discontinuing antituberculous drugs) [6]. In our review, we evaluated the 
following parameters: clinical manifestations, results of diagnostic tests, and treatment. In these 
patients (Table 1), the main symptoms were hoarseness, dysphonia, odynophagia, cough, and fever, 
and biopsy samples of tissue revealed granulomatous inflammation. The treatment of TB may be 
complex, and drug resistance often develops [14,15]. Standard therapeutic agents include isoniazid, 
rifampicin, and pyrazinamide, although modifications of therapy because of cost have been reported 
in the literature [10]; neither of the patients were given rifampicin because it would have 
necessitated an increase in the cyclosporine dose and, consequently, the cost of therapy. 
Since laryngeal TB in renal transplant recipients is an atypical presentation of TB, the diagnosis 
may be delayed, which can lead to increased morbidity and exposure of the patients’ contacts, 
particularly through nosocomial transmission. The mechanism of laryngeal involvement is 
postulated to be through bronchogenic spread, with infected sputum from the lungs directly 
contaminating the larynx. However, this theory has been challenged by other authors [9], who 
suggested that hematogenous spread is responsible for laryngeal seeding. 
Immunosuppressive drugs promote reactivation of latent TB and acquisition of new disease. In 
many studies [10-12], the main symptoms that forced patients to seek medical attention were severe 
fever and severe odynophagia, although patients had already had other symptoms, such as 
dysphonia and asthenia, for weeks. The differential diagnosis must include laryngeal TB. Larynx 
assessment with advanced endoscopy and narrow-band imaging enables diagnosis [16]. We used 
endoscopes capable of narrow-band imaging to rule out suspected malignant lesions of the larynx 
because our institution is a referral center for the treatment of laryngeal cancer in Italy. Whitish 
lesions of larynx could occur in many types of diseases, ranging from benign hyperkeratosis to 
squamous cell carcinoma. Other clinical conditions included in the differential diagnosis are 
sarcoidosis, Wegener’s granulomatosis, syphilis, histoplasmosis, blastomycosis, 
coccidioidomycosis, cryptococcosis, amyloidosis, traumatic polypoid granulation, and laryngeal 
papilloma [16-18]. Thus, biopsy may be performed for differential diagnostic purpose. 
In two cases in the literature, standard treatment was isoniazid, rifampicin, and pyrazinamide, 
although both patients required threefold increases in the daily cyclosporine dosage to maintain 
therapeutic levels. Because of the drug interaction between rifampicin and cyclosporine, the dosage 
of cyclosporine must be increased substantially when it is coadministered with rifampicin [19, 20]. 
The results of both randomized and nonrandomized studies support the value of isoniazid as TB 
prophylaxis in renal transplant recipients at risk for active infection [21]. Clinicians should consider 
prophylaxis in renal transplant recipients in endemic areas or in recipients in nonendemic countries 
who are at risk. We treated our patient with isoniazid because she was at risk for active infection, 
according to the literature [22-25]. However, the evidence of the benefit of isoniazid prophylaxis in 
renal transplantation is not robust, and a large multicenter trial is needed to investigate isoniazid 
prophylaxis in kidney transplantation in an endemic area [26]. 
Laryngeal TB is rare in kidney transplant recipients who developed TB. The few cases reported in 
the literature indicate that laryngeal symptoms (dysphonia, dysphagia) in such patients must be 
assessed adequately, even in industrialized countries in which TB is not widespread. In these cases, 
prognosis is excellent and recovery is often achieved. When whitish lesions are found in the larynx, 
diagnostic tests for TB must be performed. 
CONCLUSION 
Laryngeal TB should be considered in renal allograft recipients with hoarseness. A more rapid 
diagnosis of TB in renal transplant recipients is desirable when the site involved, such as the larynx, 
exhibits specific manifestations and the patient exhibits specific symptoms. In these cases, 
prognosis is excellent, and with adequate treatment, a complete recovery is often achieved. 
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FIGURES AND TABLES 
 
FIGURE 1. Laryngoscopic images. (A) Before antitubercular therapy. Swelling of the right false vocal fold 
with a whitish lesion, normal motility, and respiratory space. (B). After antitubercular therapy. Normal motility 
and structure of larynx, with normal respiratory space. 
 
 
FIGURE 2. Eosin and hematoxylin staining of the sampled mucosa under low- (A) and high-power (B) 
magnification illustrates the lymphocyte-rich inflammatory infiltrates along with multiple small, 
nonnecrotizing granulomas (arrows in A and B). The immunohistochemical stain for CD68R (C) highlights 
the small granulomatous aggregates of histiocytes. Bars represent 100 µm in A and 50 µm in B and C. 
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TABLE 1. Cases of laryngeal tuberculosis reported in the literature 
Subject of 
study 
No. of 
patients 
Clinical 
manifestation 
Diagnostic tests Treatment 
Laryngeal 
tuberculosis in 
renal 
transplant 
recipients [6] 
2 Prolonged 
hoarseness and 
painful 
dysphagia 
Histological study of 
laryngeal biopsy sample 
revealed large numbers of 
inflammatory cells, scattered 
epithelioid cells, and 
histiocytes along with a few 
multinucleated giant cells and 
a few areas of necrosis. Ziehl-
Nielsen staining was strongly 
positive for acid-fast bacilli.  
No different from 
tuberculosis elsewhere. 
Neither patient was 
given rifampicin 
because it would have 
necessitated an increase 
in the cyclosporine 
dose and, consequently, 
the cost of therapy 
Laryngeal 
tuberculosis in 
renal allograft 
recipients [7] 
2 2-week febrile 
illness with 
hoarseness and 
dysphagia 
Direct laryngoscopy and 
sputum results were positive 
for acid-fast bacilli that 
subsequently grew 
Mycobacterium tuberculosis 
Isoniazid, rifampicin, 
and pyrazinamide in 
each case; both patients 
required threefold 
increases in daily 
cyclosporine dosage to 
maintain therapeutic 
levels. 
Atypical 
localization of 
tuberculosis in 
kidney 
transplant 
recipients [4] 
1 Dysphonia with 
whitish lesions 
on arytenoid 
cartilage and 
epiglottis 
Direct laryngoscopy with 
laryngeal biopsy revealed 
tuberculoid granulomatous 
chronic laryngitis. Ziehl-
Neelsen staining and 
Löwenstein test yielded 
positive results. Acid-fast 
Isoniazid, rifampicin, 
and pyrazinamide for 2 
months and isoniazid 
and rifampicin for 9 
months 
bacilli were demonstrated in 
sputum 
Tuberculous 
infection in 
southern 
Chinese renal 
transplant 
recipients [5] 
2 Hoarseness of 
voice, fever, 
cough 
Direct laryngoscopy with 
laryngeal biopsy, test of 
sputum, bronchoalveolar 
lavage, and chest radiography 
were performed. Laryngeal 
biopsy revealed typical 
caseating granulomata and 
acid-fast bacilli 
Both patients received 
isoniazid, 300 mg/day; 
rifampicin, 450–600 
mg/day; and 
pyrazinamide, 1.5–2 
g/day. Pyrazinamide 
was stopped after 3 
months 
Tuberculosis in 
kidney 
transplant 
recipients [8] 
1 Fever, dysphonia Direct laryngoscopy with 
laryngeal biopsy 
demonstrated acid-fast bacilli 
in sputum 
 
 
 
 
 
 
